IYR | RWR | IYR / RWR | |
Gain YTD | 5.974 | 1.128 | 529% |
Net Assets | 3.82B | 1.83B | 209% |
Total Expense Ratio | 0.39 | 0.25 | 156% |
Turnover | 7.00 | 4.00 | 175% |
Yield | 2.49 | 3.93 | 63% |
Fund Existence | 25 years | 24 years | - |
IYR | RWR | |
---|---|---|
RSI ODDS (%) | 3 days ago86% | N/A |
Stochastic ODDS (%) | 3 days ago80% | 3 days ago79% |
Momentum ODDS (%) | 3 days ago85% | 3 days ago89% |
MACD ODDS (%) | 3 days ago88% | 3 days ago85% |
TrendWeek ODDS (%) | 3 days ago86% | 3 days ago87% |
TrendMonth ODDS (%) | 3 days ago85% | 3 days ago86% |
Advances ODDS (%) | 5 days ago85% | 5 days ago85% |
Declines ODDS (%) | 3 days ago85% | 3 days ago84% |
BollingerBands ODDS (%) | 3 days ago90% | 3 days ago84% |
Aroon ODDS (%) | 3 days ago82% | 4 days ago81% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ASVRX | 9.84 | 0.07 | +0.72% |
American Century Small Cap Value R | |||
VTSMX | 152.62 | 0.67 | +0.44% |
Vanguard Total Stock Mkt Idx Inv | |||
GSLLX | 23.27 | 0.09 | +0.39% |
Goldman Sachs Enhanced U.S. Equity Inv | |||
PDIAX | 22.54 | 0.07 | +0.31% |
Virtus KAR Equity Income A | |||
FIJYX | 31.04 | N/A | N/A |
Fidelity Advisor Biotechnology Z |
A.I.dvisor indicates that over the last year, IYR has been closely correlated with EXR. These tickers have moved in lockstep 85% of the time. This A.I.-generated data suggests there is a high statistical probability that if IYR jumps, then EXR could also see price increases.
A.I.dvisor indicates that over the last year, RWR has been closely correlated with UDR. These tickers have moved in lockstep 87% of the time. This A.I.-generated data suggests there is a high statistical probability that if RWR jumps, then UDR could also see price increases.